Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Deepak Chemtex Ltd

DEEPAKCHEM
BSE
95.99
6.24%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Deepak Chemtex Ltd

DEEPAKCHEM
BSE
95.99
6.24%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
104Cr
Close
Close Price
95.99
Industry
Industry
Dyes & Pigments
PE
Price To Earnings
1.43
PS
Price To Sales
1.46
Revenue
Revenue
72Cr
Rev Gr TTM
Revenue Growth TTM
7.60%
PAT Gr TTM
PAT Growth TTM
31.76%
Peer Comparison
How does DEEPAKCHEM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
DEEPAKCHEM
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Revenue
RevenueCr
2228394131
Growth YoY
Revenue Growth YoY%
78.847.0-20.4
Expenses
ExpensesCr
1824313225
Operating Profit
Operating ProfitCr
44896
OPM
OPM%
19.013.720.021.519.6
Other Income
Other IncomeCr
01121
Interest Expense
Interest ExpenseCr
00000
Depreciation
DepreciationCr
00111
PBT
PBTCr
558107
Tax
TaxCr
11221
PAT
PATCr
33674
Growth YoY
PAT Growth YoY%
81.3140.2-23.2
NPM
NPM%
14.310.414.516.914.0
EPS
EPS
0.026.35.263.34.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
5446497872
Growth
Revenue Growth%
-14.36.059.2-8.6
Expenses
ExpensesCr
4839416257
Operating Profit
Operating ProfitCr
6881615
OPM
OPM%
11.016.816.121.120.6
Other Income
Other IncomeCr
01133
Interest Expense
Interest ExpenseCr
00000
Depreciation
DepreciationCr
11122
PBT
PBTCr
6881717
Tax
TaxCr
12244
PAT
PATCr
4661311
Growth
PAT Growth%
44.6-2.4109.4-10.5
NPM
NPM%
7.813.212.216.015.7
EPS
EPS
5.3122.655.011.567.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
111111
Reserves
ReservesCr
9153144
Current Liabilities
Current LiabilitiesCr
78914
Non Current Liabilities
Non Current LiabilitiesCr
0001
Total Liabilities
Total LiabilitiesCr
17245170
Current Assets
Current AssetsCr
14194347
Non Current Assets
Non Current AssetsCr
35824
Total Assets
Total AssetsCr
17245170

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
132-3
Investing Cash Flow
Investing Cash FlowCr
-1-2-4-16
Financing Cash Flow
Financing Cash FlowCr
0-120-1
Net Cash Flow
Net Cash FlowCr
0119-21
Free Cash Flow
Free Cash FlowCr
01-2-12
CFO To PAT
CFO To PAT%
19.456.830.2-27.9
CFO To EBITDA
CFO To EBITDA%
13.844.822.8-21.1

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0072119
Price To Earnings
Price To Earnings
0.00.012.09.5
Price To Sales
Price To Sales
0.00.01.51.5
Price To Book
Price To Book
0.00.01.72.1
EV To EBITDA
EV To EBITDA
0.30.16.86.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
30.937.440.741.1
OPM
OPM%
11.016.816.121.1
NPM
NPM%
7.813.212.216.0
ROCE
ROCE%
50.448.319.030.0
ROE
ROE%
45.139.014.222.7
ROA
ROA%
24.725.711.717.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Deepak Chemtex Limited (DCL) is a specialized Indian manufacturer of high-purity synthetic organic colorants, chemical intermediates, and specialty dyes. Established in **1997** and headquartered with manufacturing operations in **Lote, Maharashtra**, the company has transitioned from a niche producer into a high-growth specialty chemicals player. Following its successful **IPO in December 2023**, which raised **₹23.04 Crores**, the company is aggressively expanding its global footprint and vertical integration into consumer-facing markets. --- ### **Specialized Product Portfolio & Market Applications** Deepak Chemtex has doubled its commercialized product basket from **50 products in FY21** to approximately **100 products by FY23**. The portfolio is engineered to meet stringent global safety standards, including **EN 71 (European Standard)** and **FD&C/D&C** specifications. * **FD&C and D&C Colors:** High-purity colorants for the food, drug, and cosmetic industries. Key products include **Acid Blue 9 (FD&C Blue No. 1)**, **Acid Violet 43 (Ext. D&C Violet No. 2)**, and **Acid Red 33**. These are available in both **solid/powder** and **liquid** formulations for beverages, confectionery, and premium cosmetics. * **Specialized & Inkjet Dyes:** Salt-free dyes specifically developed for the **inkjet industry**, alongside pond dyes for aquatic aesthetics and floral dyes. * **Agrochemical Colorants:** Specialized indicators and colorants for seed treatment, crop protection, and fertilizers. * **Industrial Colorants:** Applications in car wash products, portable sanitation, detergents, fuel, lubricants, and smoke signaling. * **Inorganic Chemicals:** Trading and manufacturing of **Sulphuric Acid**, **Zinc Sulphate**, and **Hydrochloric Acid**. --- ### **Manufacturing Infrastructure & Technical Capabilities** The company’s primary manufacturing hub is located in the **Lote MIDC (Ratnagiri District, Maharashtra)**. The facility is equipped with advanced glass-lined reactors, high-pressure reaction vessels, and purification systems. * **Core Chemical Processes:** Expertise in Sulphonation, Condensation, Bromination, Oxidation, Reduction, and High-pressure reactions. * **Capacity Expansion:** The company recently acquired the **B-91 Lote MIDC facility**, which is expected to increase dyestuff capacity by **1,500 MTPA**. * **New Product Development:** The **DCPL Speciality Unit No. 3** is awaiting "Consent to Operate" (expected **Aug/Sep 2025**), which will introduce **5 substantial new products** to the portfolio. * **Sustainability & Cost Control:** DCL has operationalized a **solar power project** across its facilities, targeted to reduce electricity expenditures by up to **80%**, significantly boosting operating margins. --- ### **Financial Performance & Capital Structure** Deepak Chemtex has maintained a growth trajectory exceeding **30%** in the most recent fiscal year, supported by three consecutive years of profitability. **Standalone Financial Highlights:** | Metric (Standalone) | FY 2022-23 | FY 2023-24 | FY 2024-25 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **₹47.84 Cr** | **₹51.59 Cr** | **₹70.50 Cr** | | **Profit Before Tax (PBT)** | **₹8.20 Cr** | **₹8.85 Cr** | **₹13.77 Cr** | | **Net Profit (PAT)** | **₹6.15 Cr** | **₹6.63 Cr** | **₹10.07 Cr** | **Equity Evolution:** In 2023, the company restructured its capital to enhance liquidity: * **Stock Split:** Sub-divided share face value from **₹100** to **₹10** (June 2023). * **Bonus Issue:** Allotted shares in a **15:1 ratio** (August 2023). * **Paid-up Capital:** Currently stands at **₹10.86 Crores** comprising **1,08,64,000** equity shares. --- ### **Global Footprint & Subsidiary Strategy** The company has successfully diversified its revenue away from over-dependence on a few products, with the top 10 products' contribution dropping from **90.97% in FY21** to **75.92% in H1 FY24**. * **International Reach:** Active exports to **China, France, Mexico, Japan, Australia, the UK, and the USA**. * **Atlas Tints Inc. (USA):** A wholly-owned foreign subsidiary incorporated in **January 2025** to sell directly to end-consumers in the North American market. It is already reporting sales and profits. * **DCPL Speciality Chemicals Pvt Ltd:** Classified as a **Material Subsidiary** focusing on high-margin specialty intermediates. * **South West Corporation:** A wholly-owned subsidiary contributing to the consolidated revenue, which reached **₹50.54 crore** in FY 2023-24. --- ### **Strategic Growth Priorities** 1. **Niche Market Dominance:** Launching a **"Super Specialty" portfolio** of **4 new products** targeting global markets with limited competition. 2. **Vertical Integration:** Moving from being a pure B2B supplier to capturing higher margins through direct-to-consumer (D2C) initiatives via international subsidiaries. 3. **Geographic De-risking:** Actively securing substantial new orders from **China** and other non-US markets to mitigate potential **USA tariff threats**. 4. **Managerial Strengthening:** Appointed **Mr. Ashok Ramchandra Patil** as Executive Director in **April 2024** to align corporate governance and management trends with private sector benchmarks. 5. **Capital Allocation:** Prioritizing **internal accruals** over dividends in the short term to fund aggressive capacity expansions. --- ### **Risk Assessment & Mitigation** Management actively monitors several operational and regulatory risks: * **Regulatory Compliance:** The company has addressed past administrative lapses, including delayed **SEBI Regulation 30** intimations and **RBI ODI** compliance regarding foreign subsidiaries. Corrective filings with the **ROC** and **BSE Limited** have been completed. * **Competitive Pressure:** DCL competes with larger diversified players. Mitigation strategies include continuous **cost reduction** in production and distribution and a focus on **high-purity specialty grades** that larger players may overlook. * **Governance Enhancements:** Following a secretarial audit identifying the absence of a formal system for pre-meeting clarifications, the board is implementing more robust internal processes. * **Market Volatility:** By focusing on **Non-USA products** and "super specialty" chemicals, the company aims to insulate its top line from geopolitical trade shifts.